Draig Therapeutics
Draig Therapeutics develops neuropsychiatric medicines.
$65MSeries B
Role not disclosedSC
Schroders Capital
Activity from announced rounds
All recorded activity
- Rounds participated in
- 4
- Confirmed lead rounds
- — 4 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $1.8B 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in all activityMultiverse
Trains workforces in AI and tech skills through apprenticeships for enterprise employers
£70MGrowth
Role not disclosedWayve
Provides end-to-end AI platform for autonomous driving licensed to automakers and mobility platforms
$1.5BSeries D
Role not disclosedKinaset Therapeutics
Develops inhaled therapies for severe respiratory diseases
$103MSeries B
Role not disclosed